The Impact of Pre-Apheresis Health Related Quality of Life on Peripheral Blood Progenitor Cell Yield and Donor's Health and Outcome: Secondary Analysis of Patient-Reported Outcome Data from the RDSafe and BMT CTN 0201 Clinical Trials

Nosha Farhadfar(University of Florida Health), Galen E. Switzer(University of Pittsburgh), John R. Wingard(University of Florida Health), Sandhya R. Panch(University of Washington), Michael A. Pulsipher(Primary Children's Hospital), Gerhard Hildebrandt(University of Missouri Health System), Hemant S. Murthy(University of Florida), Brent R. Logan(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Marjolein van der Poel(Maastricht University), Bronwen E. Shaw(Royal Marsden NHS Foundation Trust), Amer Beitinjaneh(University of Miami), Raquel M. Schears(Mayo Clinic in Arizona), Hillard M. Lazarus(University Hospitals of Cleveland), Stephanie Bo‐Subait(National Marrow Donor Program), Heather E. Stefanski(National Marrow Donor Program), Hien Liu(Moffitt Cancer Center), Jessica G. Bruce(University of Pittsburgh), Amar H. Kelkar(Harvard University), Sherif M. Badawy(Northwestern University), Akshay Sharma(St. Jude Children's Research Hospital), Jaime M. Preussler(National Marrow Donor Program), Miguel Ángel Díaz(Hospital Infantil Universitario Niño Jesús), Dennis L. Confer(National Marrow Donor Program), Jack W. Hsu(University of Florida Health), Kwang Woo Ahn(Medical College of Wisconsin)
Transplantation and Cellular Therapy
June 7, 2022
Cited by 9


Related Papers